Brown Morgan, Haight Paulina, Ringel Matthew, Phay John, Esnakula Ashwini, Vazzano Jennifer, Cosgrove Casey
The Ohio State University Wexner Medical Center, Department of Obstetrics and Gynecology, United States.
The James Comprehensive Cancer Center at The Ohio State University, Department of Gynecologic Oncology, United States.
Gynecol Oncol Rep. 2024 Jul 8;54:101456. doi: 10.1016/j.gore.2024.101456. eCollection 2024 Aug.
Malignant struma ovarii is an exceedingly rare pathology with a paucity of established criteria regarding management and surveillance with recommendations largely based on case reports and retrospective data. Many authors have supported stratification of malignant struma ovarii into low vs high-risk disease with more conservative management reserved for those deemed low-risk. Here we present a unique case of recurrent metastatic malignant struma ovarii after surveillance was undertaken in the setting of initially low-risk disease.
恶性卵巢甲状腺肿是一种极为罕见的病理情况,关于其管理和监测的既定标准很少,相关建议主要基于病例报告和回顾性数据。许多作者支持将恶性卵巢甲状腺肿分为低风险和高风险疾病,对于低风险患者采用更保守的管理方法。在此,我们报告一例独特病例,该患者最初被认为是低风险疾病,在进行监测后出现复发性转移性恶性卵巢甲状腺肿。